Updating the mechanisms of common fragile site instability: how to reconcile the different views? by Benoît Le Tallec et al.
MULTI-AUTHOR REVIEW
Updating the mechanisms of common fragile site instability:
how to reconcile the different views?
Benoıˆt Le Tallec • Ste´phane Koundrioukoff •
Therese Wilhelm • Anne Letessier •
Olivier Brison • Michelle Debatisse
Received: 28 August 2014 / Accepted: 28 August 2014 / Published online: 24 September 2014
 The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract Common fragile sites (CFSs) are large chro-
mosomal regions long identified by conventional
cytogenetics as sequences prone to breakage in cells sub-
jected to replication stress. The interest in CFSs came from
their key role in the formation of DNA damage, resulting in
chromosomal rearrangements. The instability of CFSs was
notably correlated with the appearance of genome insta-
bility in precancerous lesions and during tumor
progression. Identification of the molecular mechanisms
responsible for their instability therefore represents a major
challenge. A number of data show that breaks result from
mitotic entry before replication completion but the mech-
anisms responsible for such delayed replication of CFSs
and relaxed checkpoint surveillance are still debated. In
addition, clues to the molecular events leading to breakage
just start to emerge. We present here the results of recent
reports addressing these questions.
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Introduction
The replication process should be as reliable as possible in
order to minimize mutations, but some regions of the
genome, notably common fragile sites (CFSs), appear to
raise specific problems. In recent years, their role in the
generation of gross chromosome rearrangements has
become increasingly evident, so that they are now recog-
nized as major players in chromosome instability in cancer
cells. Presently, there is a large consensus to consider that
their fragility results from mitotic entry before completion
of their replication. However, the mechanisms responsible
for this delayed replication are still hotly debated. A
common view is that CFSs are enriched in nucleotide
sequences able to form secondary structures impeding fork
progression. Stalled forks may then evolve into DNA
breaks, the main source of chromosome rearrangements.
However, new results have shown that the CFS setting is
determined epigenetically, which strongly challenges this
model. Not surprisingly, the frequency of breaks at CFSs is
enhanced in cells deficient in ATR, the apical kinase that
senses replication problems and triggers a signaling cas-
cade that delays cell cycle progression, but how normal
cells enter mitosis with incompletely replicated or damaged
genome remains an important issue. We present here the
results of recent works that shed some light on the epige-
netic setting of CFSs and on the factors contributing to
maintaining their stability.
CFS instability is tissue dependent
CFSs are megabase-long chromosomal regions identified
by conventional cytogenetics as loci prone to breakage in
cells treated with low doses of aphidicolin, an inhibitor of
B. Le Tallec  S. Koundrioukoff  T. Wilhelm  A. Letessier 
O. Brison  M. Debatisse (&)
Institut Curie, Centre de Recherche, 26 rue d’Ulm, 75248 Paris
Cedex 05, France
e-mail: michelle.debatisse@curie.fr
B. Le Tallec  S. Koundrioukoff  T. Wilhelm  A. Letessier 
O. Brison  M. Debatisse
UPMC University Paris 06, 75005 Paris, France
B. Le Tallec  S. Koundrioukoff  T. Wilhelm  A. Letessier 
O. Brison  M. Debatisse
CNRS UMR 3244, 75248 Paris, France
Cell. Mol. Life Sci. (2014) 71:4489–4494
DOI 10.1007/s00018-014-1720-2 Cellular and Molecular Life Sciences
123
replicative DNA polymerases (see D. Smith’s article in this
issue). As previously suggested [1–4], recent mapping of
CFSs in different cell types by conventional and molecular
cytogenetic approaches confirmed that their setting is tissue
dependent [5–7]. These results (i) imply that sequence
features alone cannot account for CFS instability. (ii) raise
the question of whether any chromosome region can be
fragile in one or another type of tissue. The repertoire of
CFSs is now available in lymphocytes, fibroblasts, breast
and colon epithelial cells, and erythroid cells. Interestingly,
comparison of these repertoires has revealed that approxi-
mately 50 loci account for all CFSs with break frequencies
over 1 % found across these cell types. Strikingly, many of
these loci are instable in several tissues, although their
level of fragility could vary importantly from one cell type
to the other [7]. Altogether these data suggest that a finite
number of loci constitutes the pool of CFSs and that only a
limited subset of these loci becomes fragile in a given cell
type.
Fragility correlates with the presence of large
initiation-poor regions
Genome-wide analyses of replication timing [8] together
with molecular combing have recently offered unprece-
dented opportunities to study the replication dynamics
along CFSs. FRA3B, the most active CFS in human lym-
phocytes, was notably studied using both techniques [9]. In
unperturbed lymphoblastoid cells, no differences were
observed between FRA3B and the bulk genome in terms of
fork speed and fork stalling. In aphidicolin-treated cells,
fork speed was dramatically reduced, but again there were
no differences between the bulk genome and the fragile
region. Strikingly, mapping initiation events along FRA3B
in unperturbed lymphoblastoid cells revealed an initiation-
poor region extending over 700 kb, which coincides with
the most fragile part of the site. Termination events were
found all over this region, called the core, showing that
replication completion is achieved upon merging of long-
traveling forks emanating from each flanking region. In
aphidicolin-treated cells, the core was again depleted of
initiation events, but termination events were also infre-
quent, revealing a defect in replication completion. The
latter observation can be explained by considering that fork
speed reduction impacts long-traveling forks more pro-
foundly than forks covering short distances, with
particularly deleterious effects in late replicating regions
such as FRA3B. Consistent results were obtained for
FRA6E [10] and FRA16D [9]. By contrast, FRA16C dis-
played sequence-specific fork stalling and a high density of
initiation whether the cells were treated with aphidicolin or
not [11]. However, this site actually spans the same
genomic region as FRA16B, which belongs to the category
of rare fragile sites, the instability of which has long been
shown to rely on micro- or mini-satellite repeats [12]. This
makes it difficult to consider FRA16C a proper model for
CFS instability.
Similar epigenetic features set CFSs across cell types,
but at different loci
The results described above for FRA3B, FRA16D and
FRA6E raised intriguing perspectives because recent
studies have shown that the choice of active replication
origins evolves along with cell differentiation [13].
Remarkably, in fibroblasts, the density of initiation events
was comparable in the core of FRA3B and in the bulk
genome, and the site was shown to be quite stable in these
cells [9]. In contrast, FRA1L and FRA3L, the two major
CFSs in fibroblasts, display large origin-poor core regions
in that cell type but not in lymphocytes, where they are
stable [6]. These results strongly support the role of a
paucity of initiation in CFS instability and show that
commitment to fragility of major sites relies on the very
same replication features in the different tissues, namely
late replication and a paucity of replication initiation.
Large genes constitute the pool of CFSs
It has long been reported that many CFSs co-map with very
large genes, ranging from 600 kb to more than 2 Mb
(reviewed in [14]; see also [15, 16]). The extensive CFS
mapping performed recently in different human tissues and
different species [7] together with improved annotation of
human and mouse genomes have confirmed and extended
this association, showing that between 80 and 100 % of
human CFSs, depending on the cell type, and 100 % of
those found in mouse embryonic fibroblast host genes over
300 kb long. Those genes are at least 15 times larger than
the median length of human genes (*20 kb) and account
for approximately 3 % of human genes. As an increasing
number of previously non-annotated RNAs are being cat-
alogued [17], it remains possible that the 15–20 % of CFSs
devoid of large genes host yet to be identified large tran-
scription units. Noticeably, CFSs mapped in chicken DT40
cells also correlate with large genes. The most fragile
region in DT40 cells overlaps the large FAM190A and
GRID2 genes and is therefore orthologous to human
FRA4F and murine Fra6C1 [7]. These results suggest that
the conservation of CFSs in vertebrates is linked to the
conservation of large genes and conversely that chromo-
some regions containing large genes constitute the pool of
potential CFSs for all cell types. The human genome
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contains approximately 700 such genes, sometimes orga-
nized in clusters. We thus calculated that the human pool of
CFSs could be constituted of some 450 loci. Strikingly, re-
analysis of the data provided by two reports that catalogued
focal deletions in cancers and cancer cell lines [18, 19] has
shown that large genes host 51.4 % of recurrent deletions
and that many of these genes are associated with CFSs
visible in one or the other tissues in which the sites have
now been mapped [7]. These results lead to the conclusion
that approximately half of the recurrent focal deletions
found in human cancers originate from CFSs instable in the
cell types from which the cancers derive.
Transcription and fragile site setting
A recent study of five CFSs associated with large genes has
suggested a correlation between instability and ongoing
transcription, a hypothesis that accounts well for the tissue-
dependence of fragility [20]. The authors have shown that
transcription of genes extending over 800 kb takes more
than one cell cycle, so that the transcription and replication
machineries necessarily travel concomitantly on the same
template. It was thus proposed that instability occurs when
replication forks collide with R-loops, the structures
formed by the association of the nascent transcript with the
template DNA strand. Indeed, several lines of evidence
now show that defects in mRNA processing increase
genome instability in an R-loop-dependent manner, from
yeast to mammalian cells (reviewed in [21]). However,
comparison of RNA-seq data with the map of CFSs in
HCT116 colon carcinoma cells has shown that the vast
majority of large genes expressed in these cells, including
those longer than 800 kb, are stable [7]. Thus, R-loop
formation seems insufficient per se to set CFSs, although it
may aggravate instability of otherwise committed regions.
Nevertheless, the highly recurrent association of CFSs with
large genes suggests a functional relationship that remains
to be understand.
Another type of fragile regions was recently revealed in
mouse splenic B cells upon treatment with hydroxyurea
[22]. These sites, called ER-FSs (early replicating fragile
sites), map to promoters of highly transcribed and early
replicating genes. Importantly, orthologous regions of the
human genome have been involved in approximately half
of the amplifications and deletions recurrently found in
biopsies of patients with diffuse large B cell lymphomas
(see A. Nussensweig’s article in this issue). Altogether, the
results link CFS and ER-FS instability to different types of
replication stresses arising at least in part from conflicts
between replication and transcription. Since a vast majority
of chromosome rearrangements found in cancer cells result
from the instability of either CFSs or ER-FSs, deciphering
the molecular mechanisms responsible for these conflicts
now represents a major issue in the field.
CFSs and DNA secondary structures
The actual contribution of cis-acting DNA sequences to
CFS instability is still strongly debated. Early analyses of a
few cloned CFSs have revealed that they contain subre-
gions enriched in highly flexible AT-rich sequences with
the potential to form secondary structures. It was thus
proposed that these sequences impede replication fork
progression, which may lead to fork collapse, then DNA
breaks and ultimately to chromosome rearrangements
(reviewed in [23]). In support of this model, it has since
been repeatedly reported that various types of secondary
structures, including AT-rich sequences such as those
found in CFSs, can perturb replication fork movement
in vitro and in vivo (reviewed in [24]). However, recent
genome-wide analyses of CFS sequences have provided
contrasted results regarding the presence of flexible AT-
rich regions within these sites. Indeed, some reports claim
that CFSs are highly enriched in flexible AT-rich regions
[25, 26], while others fail to identify specific accumulation
of such sequences in the sites [4, 27]. The question of
whether flexible AT-rich sequences, when present in a
given CFS, constitute preferential regions of breakage
in vivo has been extensively addressed, also leading to
inconsistent conclusions. On one hand, several analyses
have shown that DNA sequences within or adjacent to
deletion breakpoints contain AT-rich flexible motifs [28,
29], suggesting that these regions are prone to breakage.
On the other hand, deletions that remove AT-rich flexible
sequences in FRA16D [29] or FRA3B [30, 31] fail to
suppress breaks at the corresponding site. Finally, the
recently described tissue specificity of CFSs strongly
argues against an exclusive role of cis-acting DNA features
in CFSs instability.
To reconcile this whole set of results, we propose the
following scenario: upon replication stress, forks traveling
along the initiation-poor core of CFSs may further slow
down or stall if they encounter impediments such as DNA
secondary structures. These structures may thus constitute
preferential boundaries for under-replicated regions and,
consequently, appear as hotspots of breakage at mitosis. In
the absence of site-specific barriers, stress-induced fork
slowing is sufficient per se to prevent completion of rep-
lication of the large core of CFSs, which leads to more
fuzzy distribution of the borders of under-replicated
regions, and hence of the breaks. By contrast, cells dis-
playing a high density of replication initiation in the core
can rescue stalled forks, which allows completion of rep-
lication in all conditions and prevents mitotic breakage. In
Updating the mechanisms of common fragile site instability 4491
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this hypothesis, trans-acting factors that help the replication
machinery to cope with fork barriers are also expected to
participate in CFSs stability. Consistently, several works
have recently shown that depletion of the Rev3 subunit of
pol zeta, or of pol eta and possibly of pol kappa, three
specialized DNA polymerases that facilitate DNA synthe-
sis through non-canonical DNA structures [24], increases
CFS instability [32, 33]. Furthermore, the absence of ade-
quate trans-lesion polymerases favors accumulation of
DNA lesions such as abasic sites, which could also com-
promise completion of replication of the CFS core.
How can normal cells enter mitosis
with under-replicated CFSs?
Faithful duplication of the genetic information before
chromosome segregation is fundamental to the mainte-
nance of genome integrity. To coordinate replication with
mitosis, the cells have evolved a global signaling network
that senses problems arising in S phase, stabilizes stalled
forks, delays mitotic onset and stimulates DNA repair and/
or apoptosis (reviewed in [34]). Breaks at CFSs are a major
source of genome instability in pre-neoplastic lesions (see
V. Gourgoulis’s article in this issue), but how checkpoint-
proficient cells escape surveillance and continue cycling
with an incompletely replicated genome has remained
unclear. A recent report [35] has shown that moderate fork
speed reductions resembling those eliciting breakage at
CFSs still allow cell cycle progression. Chromatin loading
of sensors and mediators of the ATR pathway occurs in
these conditions, but neither CHK1 nor p53 is activated.
Accordingly, the authors found that the replisome disas-
sembles upon moderate fork slowing in cells depleted of
ATR, but not in cells depleted of CHK1. Partial activation
of the pathway thus takes steps against fork collapse but
tolerates S-phase progression and mitotic onset with
incompletely replicated genome under moderate stress.
Behavior of under-replicated regions at mitosis
and beyond
The fact that the checkpoint fails to delay mitotic onset
when only a few long-traveling forks remain active raises
questions about the fate of persisting replication interme-
diates. Interestingly, the frequency of anaphase bridges,
thought to represent unresolved replication or recombina-
tion intermediates, increases markedly upon moderate
replication stress. It has been observed that the BLM he-
licase coats the bridges, while FANCD2-FANCI foci mark
their tips. In addition, daughter cells display lesions
sequestered in 53BP1 nuclear bodies in the following G1
phase. Not surprisingly, CFS sequences are enriched in
those bodies (reviewed in [36]). Two recent works [37, 38]
reported that the endonucleases MUS81/EME1 and
ERCC1, which contribute to processing a wide variety of
DNA structures such as stalled forks and Holliday junc-
tions, are involved in the maintenance of CFSs during
mitosis. SNM1B/APOLLO, a nuclease involved in the
FANC pathway, also contributes to stabilizing CFSs [39].
Together, these results strongly suggest that segregation of
incompletely replicated chromosomes can still be rescued
through accurate processing of non-replicated DNA and
that formation of 53BP1 bodies favors faithful repair and/
or replication completion in the next cell cycle.
DNA damage response (DDR) and CFS instability
A large number of DDR proteins are involved in the
maintenance of CFS stability, notably ATR, CHK1,
BRCA1, RAD51, Claspin, FANC proteins and BLM
(reviewed in [40]). Strikingly, depletion of most of these
proteins leads to fork slowing, raising the question of
whether they control the stability of CFS via their functions
in the DDR or via their indirect impact on fork velocity. A
recent work focusing on the impact of ATR or CHK1
depletion on genome stability [35] has shown that the
increased frequency of breaks at CFSs in the absence of
CHK1 is completely accounted for by fork slowing, while
ATR function is crucial to both sustaining global fork
progression and avoiding disassembly and Mre11-depen-
dent resection of long-traveling forks. In addition, some of
the large genes nested in CFSs, such as FHIT in FRA3B,
SPIDR/KIAA0146 in FRA8I and WWOX in FRA16D, have
been involved in DNA surveillance and/or repair pathways
(see K. Huebner’s and R. Aqeilan’s articles in this issue).
Their early inactivation in precancerous lesions might
therefore further enhance genome instability.
Conclusion
Instability of major CFSs has now been associated with late
replication combined with a paucity of initiation events
along a large DNA sequence called the core. The core has
consequently to be replicated by long-traveling forks
coming from flanking regions. All impediments slowing
the progression of these forks increase the risk that cells
will reach mitosis before complete replication of the core,
leading to deleterious effects on CFS stability. Among
others, DNA secondary structures and R-loops as well as
mutations affecting proteins that contribute to erase either
type of barrier participate to under-replication of the core
and therefore enhance CFS instability.
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The striking association of CFSs with large genes indi-
cates a major role of these genes in fragility, but further
work is needed to decipher the relationships linking fra-
gility and transcription at the molecular level. One
possibility could be that CFS setting relies on large-scale
chromatin domains shaped by the association of tran-
scription control elements such as insulators, promoters,
terminators and enhancers of their cognate genes. These
flexible domains would govern local replication timing and
origin density in the different cell types. Alternatively,
ongoing transcription machinery could clear or impair the
recruitment of the pre-replication complex along the core
of the genes.
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